Clinical trial
Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin…
NCT00278642 · Richard Burt, MD, Other · Terminated
Key facts
| NCT number | NCT00278642 |
|---|---|
| Title | Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders |
| Official title | High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders: A Phase I Trial |
| Lead sponsor | Richard Burt, MD, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pemphigus |
| Intervention type | Biological |
| Interventions | Hematopoietic stem cell transplantation |
| Enrollment | 1 |
| Start date | Sep 1, 2002 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Jan 18, 2006 |
| Last update posted | Apr 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: